Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes.
about
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile.Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study
P2860
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Integrated analysis of three b ...... ological eradication outcomes.
@ast
Integrated analysis of three b ...... ological eradication outcomes.
@en
type
label
Integrated analysis of three b ...... ological eradication outcomes.
@ast
Integrated analysis of three b ...... ological eradication outcomes.
@en
prefLabel
Integrated analysis of three b ...... ological eradication outcomes.
@ast
Integrated analysis of three b ...... ological eradication outcomes.
@en
P2093
P2860
P356
P1476
Integrated analysis of three b ...... ological eradication outcomes.
@en
P2093
Dale W Usner
Heleen H Decory
Lynne S Gearinger
Michael R Paterno
Timothy L Comstock
Timothy W Morris
Wolfgang Haas
P2860
P304
P356
10.2147/OPTH.S23518
P407
P577
2011-09-21T00:00:00Z